Methods Of Treatment Of Pterygium Using An Anti-VEGF Agent

COMPOSITIONS AND METHODS FOR TREATING INFECTIOUS DISEASES

DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS

COMPOSITIONS AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM INJURY

BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD20 and CD19

CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN

NK CELLS WITH AN INCREASED ANTIBODY-DEPENDENT CELLULAR TOXICITY (ADCC) AGAINST TUMORS

CYTOTOXICITY TARGETING CHIMERAS

HEPARANASE-NEUTRALIZING A54 MONOCLONAL ANTIBODY

ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF

METHODS OF TREATING CANCER WITH ANTI-HER2 BIPARATOPIC ANTIBODIES

ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF

TREATMENT AND PREVENTION OF CANCER USING HER3 ANTIGEN-BINDING MOLECULES

SEMENOGELIN NEUTRALIZING ANTIBODY AND EPITOPE AND APPLICATION THEREOF

ANTI-CD73 ANTIBODIES AND USE THEREOF

Methods For Prevention Of Graft Rejection In Xenotransplantation

METHODS FOR ADMINISTERING A BCMAXCD3 BINDING MOLECULE

HUMAN LIFR ANTIGEN BINDING PROTEIN, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

ANTI-GLYCO-CMET ANTIBODIES AND THEIR USES

ANTIBODIES SPECIFICALLY RECOGNIZING FCRN AND USES THEREOF

ANTI-B7-H7 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF

ANTI-B7-H4 ANTIBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

ANTIBODIES TO PROGRAMMED CELL DEATH PROTEIN 1 THAT ARE PD-1 AGONISTS

MULTISPECIFIC BINDING PROTEIN COMPOSITIONS AND USES THEREOF

STABILIZED CD3 ANTIGEN BINDING AGENTS AND METHODS OF USE THEREOF

ANTI-CD101 ANTIBODY AND USE THEREOF

TREM2 STABILIZING ANTIBODIES

Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigens

ANTI-SIGLEC-3 ANTIBODIES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF

NKp46-Binding Polypeptides and Uses Thereof

BISPECIFIC ANTIGEN-BINDING MOLECULE AND USE THEREOF

METHOD OF IMPROVING THE CONSISTENCY AND/OR QUALITY OF A FELINE ANTIBODY

Treatment Of Chronic Obstructive Pulmonary Disease With An Anti-Interleukin-33 Antibody

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

USAG-1 MOLECULE-TARGETING NEUTRALIZING ANTIBODY FOR TOOTH REGENERATION TREATMENT

ANTI-VEGF ANTIBODY CONSTRUCTS AND RELATED METHODS FOR TREATING VESTIBULAR SCHWANNOMA ASSOCIATED SYMPTOMS

Monoclonal Antibodies Against Alpha-Synuclein Fibrils

ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF

CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF

FGF21 Mutants and Uses Thereof

DUAL CYTOKINE FUSION PROTEINS COMPRISING IL-10

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY IN CTDNA HIGH RISK PATIENTS

TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY

RNA CANCER VACCINES

BISPECIFIC RECOMBINANT PROTEIN AND USE THEREOF

MMP13 BINDING IMMUNOGLOBULINS

ANTIBODIES BINDING TO HLA-A2/WT1

Combination Therapy Involving Anti-CD39 Antibodies and Anti-PD-1 or Anti-PD-L1 Antibodies

ANTI-4-1-1BBXCCR8 ANTIBODIES AND USES THEREOF

HUMAN CGRP RECEPTOR BINDING PROTEINS

CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS

EPO RECEPTOR AGONISTS AND ANTAGONISTS

DUAL SPECIFICITY ANTIBODIES TO PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR

ANTI-PD-1 ANTIBODIES AND USES THEREOF

METHODS OF TREATING CANCER USING ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1

METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS

FUSION PROTEIN CONTAINING ANTI-TIGIT ANTIBODY AND TGF-ßR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

METHODS FOR TREATING HEPCIDIN-MEDIATED DISORDERS

ANTIBODIES THAT BIND INTERLEUKIN 13 AND METHODS OF USE

Method of Treating Psoriasis with Anti-IL23 Specific Antibody

IMPROVED Fc SILENCED ANTI-oxMIF ANTIBODIES WITH REDUCED AGGREGATION POTENTIAL AND REDUCED HYDROPHOBICITY

EPO RECEPTOR AGONISTS AND ANTAGONISTS

COMBINED CANCER THERAPY WITH AN EPITHELIAL CELL ADHESION MOLECULE (EPCAM) INHIBITOR AND A WNT INHIBITOR

BI- AND MULTIVALENT ALBUMIN BINDERS

ANTIBODY FOR TETANUS TOXIN AND USE THEREOF

ANTI-HCMV ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF

RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

METHODS AND COMPOSITIONS FOR TARGETING DISEASE RELATED CELL SURFACE RECEPTORS USING RADIOLABELED AND/OR CYTOTOXIN LABELLED ANTIBODIES

EGFR TARGETED THERAPY

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

TREATMENT OF AUTOIMMUNE ENCEPHALITIS WITH SATRALIZUMAB

METHODS FOR TREATING NEUROBLASTOMA

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

FCRN/HSA BINDING MOLECULES AND METHODS OF USE

Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same

TARGETING MUTANT KRAS WITH A MUTATION SPECIFIC IGA

BISPECIFIC ANTIGEN BINDING CONSTRUCTS TARGETING HER2

ANTI-HUMAN CD45RC ANTIBODIES AND USES THEREOF

ANTI-CD20 x ANTI-CD28 COMBINATION THERAPIES

BISPECIFIC ANTIBODY AND USE THEREOF

TREATMENT OF LUPUS

CSF3R AS BIOMARKER AND THERAPEUTIC TARGET FOR PULMONARY FIBROSIS

ANTI-EGFR/MET ANTIBODIES AND USES THEREOF

ANTI-TRKA ANTIBODIES AND USES THEREOF

Anti-CD161 antibodies and uses thereof

METHODS OF TREATING OR PREVENTING GRAFT VERSUS HOST DISEASE

FCRN BINDING MOLECULES AND METHODS OF USE

INTERLEUKIN-2 MUTEINS, FUSION PROTEINS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS

COMPOSITION FOR CYTOTOXIC T CELL DEPLETION

HUMANIZED ANTI-CLAUDIN-1 ANTIBODIES AND USES THEREOF

ANTI-INTERLEUKIN-9 ANTIBODY AND USE THEREOF

ANTIBODY VARIANTS

SELECTIVE AND POTENT INHIBITORY ANTIBODIES OF MYOSTATIN ACTIVATION

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA

ANTI-DKK1 ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

INTRADERMAL ADMINISTRATION OF IMMUNOGLOBULIN G PREPARATION

Recombinant Fusion Proteins Comprising Interleukin- 18-Binding Protein and Antigen Binding Fragment to Serum Albumin, and Compositions and Uses Thereof

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES

PTK7 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

T CELL BINDING COMPOSITIONS AND METHODS

ADAM9-Binding Molecules, and Methods of Use Thereof

CANINE ANTI-NGF ANTIBODIES AND METHODS OF TREATING PAIN THEREOF

ANTI-CCR8 ANTIBODIES AND METHODS OF USE

BISPECIFIC ANTIBODY AGAINST ALPHA-SYN/IGF1R AND USE THEREOF

ANTI-CTLA4/OX40 BISPECIFIC ANTIBODIES AND USES THEREOF

AGONISTIC ANTIBODIES THAT BIND CD40

METHODS OF TREATING CANCER WITH A COMBINATION OF A TAAxCD3 BISPECIFIC ANTIBODY AND A TARGETED IMMUNOCYTOKINE

MODIFIED IMMUNE CELLS AND METHODS FOR USE THEREOF

STABLE ANTI-OSMR ANTIBODY FORMULATION

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICRENVIRONMENT

BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

ACTIVATABLE BISPECIFIC ANTI-CD3 AND ANTI-PD-L1 PROTEINS AND USES THEREOF

ANTAGONISTIC PD-1, PD-L1 AND LAG-3 BINDING PROTEINS

COMPOSITIONS COMPRISING ANTIBODIES THAT BIND GAMMA-DELTA T CELL RECEPTORS

Gamma Delta T-Cell-Targeted Modified IL-2 Polypeptides and Uses Thereof

APPROVED PRODUCTS FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC HEART DISEASE

DUAL SPECIFIC ANTIBODIES

NOVEL ANTIGEN BINDING MOLECULE FORMATS

METHOD FOR MODULATING APPETITE

METHODS FOR ALTERING BODY COMPOSITION BY ADMINISTERING A GDF8 INHIBITOR AND AN ACTIVIN A INHIBITOR

MYELOPROLIFERATIVE CONDITIONS

MONOCLONAL ANTIBODY AND ANTIGENS FOR DIAGNOSING AND TREATING LUNG DISEASE AND INJURY

PREVENTATIVE TREATMENT OF MIGRAINE

SARS-CoV-2 BINDING PROTEINS AND METHODS OF USE THEREOF

COMPOUND-LINKER CONSTRUCTS COMPRISING NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF

KIR3DL3 AS AN HHLA2 RECEPTOR, ANTI-HHLA2 ANTIBODIES, AND USES THEREOF

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

THERAPEUTIC AGENT FOR CANCER

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

LEUKEMIA-RELATED MARKER AND USE THEREOF

METHODS, COMPOSITIONS AND KITS FOR TREATING A SUBJECT USING A RECOMBINANT HETEROMULTIMERIC NEUTRALIZING BINDING PROTEIN

DEVELOPMENT OF NANOBODIES AS FIRST-IN-CLASS INHIBITORS FOR THE DENEDDYLATING ENZYME NEDP1

COMBINATION THERAPY OF ANTI-TYRP1/ANTI-CD3 BISPECIFIC ANTIBODIES AND TYRP1-SPECIFIC ANTIBODIES

CHIMERIC POLYPEPTIDE COMPOSITIONS AND ENCODING POLYNUCLEOTIDES THEREOF

ANTIBODY SPECIFICALLY BINDING TO MUC-1 AND USES THEREOF

ANTI-GLYCO-MUC4 ANTIBODIES AND THEIR USES

MULTISPECIFIC BINDING MOLECULES COMPRISING LTBR AND EDB BINDING DOMAINS AND USES THEREOF

METHOD OF TREATING IGA NEPHROPATHY BY ADMINISTERING ALTERED ANTIBODIES WHICH BIND HUMAN A PROLIFERATION-INDUCING LIGAND (APRIL) PROTEIN

ANTIBODIES SPECIFICALLY RECOGNIZING FASL AND USES THEREOF

ANTIBODY MOLECULES

METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

ANTI-MET FAB-FC FOR THE TREATMENT OF A TUMOR AND/OR METASTASIS

KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLETING ANTIBODIES

FCRN ANTAGONISTS AND METHODS OF USE

ANTIBODY INDUCING IMMUNE TOLERANCE, INDUCED LYMPHOCYTE, AND CELL THERAPY AGENT THERAPEUTIC METHOD USING INDUCED LYMPHOCYTE

METHODS TO ENHANCE THERAPEUTIC EFFICACY IN MELANOMA VIA MODULATION OF CELL SURFACE PD-L1/L2

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA

ANTI-TREM2 ANTIBODIES AND METHODS OF USE

ANTI-NKG2A ANTIBODIES AND USES THEREOF

CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T) FOR THE TREATMENT OF CANCER

METHODS FOR TREATING ACUTE MYELOID LEUKEMIA WITH ANTI-ILT3 ANTIBODIES

METHODS, COMPOSITIONS AND DOSING REGIMENS FOR TREATING OR PREVENTING INTERFERON-GAMMA RELATED INDICATIONS

ANTI IL-6 DOMAIN ANTIBODIES

ANTI-IL-23 ANTIBODIES

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

TAU THERAPY

MONOCLONAL ANTIBODIES THAT SPECIFICALLY BIND TO MATRILIN 3 AND THEIR USE

HUMAN NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 HAVING BREADTH TO VARIANT STRAINS, AND ANTIGEN-BINDING FRAGMENT THEREOF

COMPOSITIONS AND METHODS FOR PREVENTING OR AMELIORATING NEONATAL HSV INFECTION

EPITOPE PEPTIDE AND ANTIBODY FOR TREATING HBV INFECTION AND RELATED DISEASES

COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES

HYDROGEL-BASED DELIVERY SYSTEM FOR INDUCTION OF INTRATUMORAL TERTIARY LYMPHOID STRUCTURES AND AUGMENTATION OF IMMUNE CHECKPOINT BLOCKADE AND METHODS THEREOF

PHARMACEUTICAL COMPOSITIONS OF ANTI-IGF-1R ANTIBODIES

TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)

USES OF GAMMA DELTA T CELL ACTIVATING ANTIBODIES

TREATMENT OF GASTRIC CANCER AND/OR GASTROESOPHAGEAL JUNCTION CANCER

MULTISPECIFIC MOLECULES BINDING TO TCR AND USES THEREOF

Recombinant RNA Molecules Comprising Untranslated Regions or Segments Encoding Spike Protein from the Omicron Strain of Severe Acute Respiratory Coronavirus-2

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES, CONTAINING GLUCAGON-LIKE PEPTIDE-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST

METHOD OF TREATING A TUMOR WITH A COMBINATION OF IL-7 PROTEIN AND VEGF ANTAGONIST

PHARMACEUTICAL COMBINATION FOR TREATING TUMORS AND USE THEREOF

REGIMEN FOR SUPPRESSING ORGAN REJECTION

METHODS OF TREATING AMYLOID RELATED BRAIN DISORDERS USING NOVEL COMPOUNDS AND ANTIBODIES

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

METHOD FOR HIGH THROUGHPUT PEPTIDE-MHC AFFINITY SCREENING FOR TCR LIGANDS

T CELL ENGAGERS

HUMANIZED ANTI QUIESCIN SUEFHYDRYE OXIDASE 1 (QSOX1) ANTIBODIES AND USES THEREOF

METHODS FOR INHIBITING FIBROSIS IN A SUBJECT IN NEED THEREOF

DE-CLUSTERING INHIBITORS OF PTPRA

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

BAFF-R TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T-CELLS AND USES THEREOF

HUMAN ANTIBODIES TO PD-L1

ANTIBODY AND USE THEREOF

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA

COMPOSITIONS AND METHODS USEFUL IN PROMOTING MILK PRODUCTION

FOLR1 PROTEASE-ACTIVATABLE T CELL BISPECIFIC ANTIBODIES

TREATMENT AND PREVENTION OF ALCOHOLIC LIVER DISEASE

ANTIBODY MOLECULE AGAINST GROWTH AND DIFFERENTIATION FACTOR 15 AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS

T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof

VHH MASKED CYTOKINES AND METHODS OF USE THEREOF

TARGETING CLPTM1L FOR TREATMENT AND PREVENTION OF CANCER

ANTI-MESOTHELIN ANTIBODY AND ANTIBODY DRUG CONJUGATE THEREOF

GPC3 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

ANTI-CDH6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES THEREOF

COMBINATION THERAPY WITH AN ANTI-CD19 ANTIBODY AND PARSACLISIB

Radiohalogenated Agents for in Situ Immune Modulated Cancer Vaccination

Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody

PHARMACEUTICAL COMPOSITION OR DRUG KIT FOR ALLEVIATING OR TREATING FIBROTIC DISEASES, AND USE THEREOF

VECTOR CONSTRUCTS FOR DELIVERY OF NUCLEIC ACIDS ENCODING THERAPEUTIC ANTI-IGF-1R ANTIBODIES AND METHODS OF USING THE SAME

METHODS OF PREVENTING AND TREATING ABNORMAL CALCIUM SPARKS

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2

ENGINEERED COMPOSITIONS FOR BONE-TARGETED THERAPY

ANTIBODY SPECIFIC FOR MUCIN-1 AND METHODS OF USE THEREOF

PERTUZUMAB VARIANTS AND EVALUATION THEREOF

ANTI-CD98 ANTIBODIES AND USES THEREOF

FC BINDING FRAGMENTS COMPRISING A CD137 ANTIGEN-BINDING SITE

THERAPEUTIC BINDING MOLECULES

TrkA ANTIBODY AND APPLICATION THEREOF

METHODS FOR TREATING MYOSITIS USING FCRN ANTAGONISTS

BISPECIFIC HUMANIZED SINGLE DOMAIN ANTIBODY TO PD-L1 AND CD47, AND USE THEREOF

NK/MONOCYTE ENGAGERS

STABLE HIGH CONCENTRATION SODIUM CHLORIDE FORMULATIONS CONTAINING PD-1 ANTIBODY AND METHODS OF USE THEREOF

METHODS OF USE OF ANTI-TREM2 ANTIBODIES

COMPOSITIONS AND METHODS FOR MODULATING LAIR SIGNAL TRANSDUCTION

ANTIBODIES TARGETING CDH19 FOR MELANOMA

MCT11 ANTIBODIES TO TREAT T CELL FUNCTIONAL EXHAUSTION AND ENHANCE CANCER IMMUNOTHERAPY

ANTI-CLL-1 ANTIBODIES AND USES THEREOF

ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU

ANTI-HSP70 ANTIBODIES AND THERAPEUTIC USES THEREOF

INHIBITION OF EOSINOPHILIC TRAPS

METHODS OF TREATING AL AMYLOIDOSIS

METHODS AND COMPOSITIONS FOR DOSING OF ALLOGENEIC CHIMERIC ANTIGEN RECEPTOR T CELLS

Method of Redirecting T Cells to Treat HIV Infection

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

COMBINATION THERAPY USING EXOSOME SECRETION INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS

METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST

ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX

COMBINED USE OF MULTIKINASE INHIBITOR

TREATMENT AND PREVENTION OF GLOMERULAR DISEASE

ANTI-MYOSTATIN ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE

USE OF ALPHA-ENOLASE ANTAGONIST IN TREATING OF FIBROTIC DISEASES

ANTI-GLYCO-MUC1 ANTIBODIES AND THEIR USES

COMBINATION THERAPY WITH A CEA X CD28 BISPECIFIC ANTIBODY AND BLOCKING ANTI-PD-1 ANTIBODIES FOR ENHANCED IN VIVO ANTI-TUMOR ACTIVITY

ANTI-GPRC5DxBCMAxCD3 TRISPECIFIC ANTIBODY AND USE THEREOF

MULTISPECIFIC CONSTRUCTS AND USES THEREOF

NOVEL DARPIN BASED CD70 ENGAGERS

ANTIBODIES TO CANINE AND FELINE ONCOSTATIN M RECEPTOR BETA AND USES THEREOF

BI-SPECIFIC ANTIBODIES AND USE THEREOF

METHODS OF TREATING NAUSEA AND VOMITING DISORDERS USING ANTI-GFRAL ANTIBODIES

PD-L1 ANTIGEN BINDING PROTEIN AND USE THEREOF

CANCER THERAPY

COMBINATION THERAPY WITH DEXAMETHASONE AND TUMOR-SPECIFIC T CELL ENGAGING MULTI-SPECIFIC ANTIBODIES FOR TREATING CANCER

Humanized and Affinity-Matured Anti-CEACAM1 Antibodies

ANTI-CD19 THERAPY IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF LEUKEMIA OR LYMPHOMA

ANTIBODIES FOR IL-17C

METHOD FOR IMPROVING WOUND HEALING

Bone-Targeting Antibodies

COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON’S DISEASE

ANTIBODIES AND METHODS FOR GENERATING THE SAME

ANTI-PTK7 IMMUNE CELL CANCER THERAPY

METHODS AND COMPOSITIONS FOR DELIVERY OF IMMUNOTHERAPY AGENTS ACROSS THE BLOOD-BRAIN BARRIER TO TREAT BRAIN CANCER

Immunoconjugates

CXCR3 LIGAND HAVING ENHANCED CXCR3-EXPRESSING CELL MIGRATION ACTIVITY

COMBINATION OF AN IMMUNOCYTOKINE COMPRISING IL-12 AND A KINASE INHIBITOR

USE OF PLINABULIN IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS

USE OF GLUCOCORTICOID RECEPTOR MODULATORS TO POTENTIATE CHECKPOINT INHIBITORS

ANTI-BETAKLOTHO ANTIBODY AND USE THEREOF

BISPECIFIC ANTIBODIES AGAINST HER2

CELL INJURY INDUCING THERAPEUTIC DRUG FOR USE IN CANCER THERAPY

Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES

AGONISTIC ANTI TNFR2 ANTIBODY MOLECULES

ANTI-CD70 ANTIBODIES, CONJUGATES THEREOF AND METHODS OF USING THE SAME

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

ANTI-EGFR/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF

USE OF INTEGRIN a5b1 INHIBITORS IN THE TREATMENT OF PULMONARY HYPERTENSION AND HEART FAILURE

ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF

METHODS TO ENHANCE EFFICACY OF COMBINED TARGETING OF IMMUNE CHECKPOINT AND MAPK PATHWAYS

C-KIT ANTIBODIES

ANTIBODY TARGETING CD22 AND CD79B

TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS

ROR1 ANTIBODIES

CLAUDIN-6 ANTIBODIES AND DRUG CONJUGATES

METHODS OF TREATING NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS USING INTERLEUKIN-17 (IL-17) ANTAGONISTS

NUCLEIC ACID MOLECULES ENCODING ANTIBODIES TO A PROLIFERATION-INDUCING LIGAND (APRIL)

METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR

COMPOSITIONS AND METHODS FOR TREATING TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY IN BLEEDING PATIENTS

ANTIBODIES TARGETING HIV ESCAPE MUTANTS

NEUTRALISING ANTIBODIES AND USES THEREOF

BLOOD-BRAIN BARRIER PERMEABLE FUSION PROTEIN AND USES THEREOF

HER2-TARGETING ANTIGEN BINDING MOLECULES COMPRISING 4-1BBL

ANTI-IL-31RA ANTIBODY-CONTAINING FORMULATIONS

PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-HUMAN TSLP RECEPTOR ANTIBODIES AND METHODS OF USING THE SAME

COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES THEREOF

HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS

METHOD OF TREATING CANCER USING A COMBINATION OF ENTINOSTAT AND AN ANTI-CSF-1R ANTIBODY

ANTI-TIGIT ANTIBODIES

ANTIBODIES THAT BIND HUMAN C6 AND USES THEREOF

METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA